Biphasic prognostic significance of PD-L1 expression status in patients with early- and locally advanced-stage non-small cell lung cancer

MLA

Koji, Teramoto, et al. “Biphasic Prognostic Significance of PD-L1 Expression Status in Patients with Early- and Locally Advanced-Stage Non-Small Cell Lung Cancer.” Cancer Immunology, Immunotherapy : CII, vol. 70, no. 4, May 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........75d973975b3001e446f800fbc4d4779e&authtype=sso&custid=ns315887.

APA

Koji, T., Tomoyuki, I., Yoko, K., Mitsuaki, I., Jun, H., Hidetoshi, S., & Yataro, D. (2020). Biphasic prognostic significance of PD-L1 expression status in patients with early- and locally advanced-stage non-small cell lung cancer. Cancer Immunology, Immunotherapy : CII, 70(4).

Chicago

Koji, Teramoto, Igarashi Tomoyuki, Kataoka Yoko, Ishida Mitsuaki, Hanaoka Jun, Sumimoto Hidetoshi, and Daigo Yataro. 2020. “Biphasic Prognostic Significance of PD-L1 Expression Status in Patients with Early- and Locally Advanced-Stage Non-Small Cell Lung Cancer.” Cancer Immunology, Immunotherapy : CII 70 (4). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........75d973975b3001e446f800fbc4d4779e&authtype=sso&custid=ns315887.